Who owns Pds Biotechnology Ord?

Tip: Access positions for across all investors

Analyze quarterly positions in Pds Biotechnology Ord with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pds Biotechnology Ord stock

Who bought or sold Pds Biotechnology Ord this quarter?

Fund or Company Name
Shares Held
Valued At
Change in Shares
As Of
Actions
Vanguard Group 1.5M $2.5M -1% Dec 2024
 View chart
BlackRock 523k $853k 7% Dec 2024
 View chart
Geode Capital Management 417k $680k 1% Dec 2024
 View chart
Susquehanna International 275k $447k 60% Dec 2024
 View chart
Citadel Advisors 235k $383k 93% Dec 2024
 View chart
William Blair $ Company 158k $257k 29% Dec 2024
 View chart
State Street Corporation 133k $217k 19% Dec 2024
 View chart
Millennium Management 126k $206k -46% Dec 2024
 View chart
HAP Trading 107k $3.8k -30% Dec 2024
 View chart
Renaissance Technologies 100k $163k 331% Dec 2024
 View chart
Northern Trust 83k $135k -11% Dec 2024
 View chart
Commonwealth Equity Services 78k $127k -1% Dec 2024
 View chart
Integrys Wealth Advisors 75k $90k 3% Mar 2025
 View chart
Two Sigma Investments 66k $107k 273% Dec 2024
 View chart
Virtu Financial 55k $89k 100% Dec 2024
 View chart
UBS Group 50k $82k 147% Dec 2024
 View chart
Vontobel Holding 40k $65k 0% Dec 2024
 View chart
Marshall Wace 39k $64k 38% Dec 2024
 View chart
Jane Street 36k $58k 100% Dec 2024
 View chart
Bank of New York Mellon 29k $48k 0% Dec 2024
 View chart
Caption Management 27k $45k -79% Dec 2024
 View chart
Bank of America Corporation 27k $44k 0% Dec 2024
 View chart
T. Rowe Price Associates 25k $41k 0% Dec 2024
 View chart
XTX Topco 25k $40k -63% Dec 2024
 View chart
Tempus Wealth Planning 19k $31k 0% Dec 2024
 View chart
Dimensional Fund Advisors 18k $30k -27% Dec 2024
 View chart
Morgan Stanley 18k $29k -35% Dec 2024
 View chart
Raymond James Financial 16k $26k 100% Dec 2024
 View chart
Wealth Group 15k $25k 0% Dec 2024
 View chart
Sherbrooke Park Advisers 14k $23k -65% Dec 2024
 View chart
Federation des caisses Desjardins du Quebec 14k $23k 53% Dec 2024
 View chart
Sandbox Financial Partners 13k $15k 100% Mar 2025
 View chart
Mercer Global Advisors 13k $20k 0% Dec 2024
 View chart
J.W. Burns & Company 10k $12k 0% Mar 2025
 View chart
Simplex Trading 8.3k $13k 23% Dec 2024
 View chart
Kathleen S. Wright Associates 7.0k $11k 0% Dec 2024
 View chart
Tower Research Capital 5.1k $8.2k 82% Dec 2024
 View chart
Advisor Group Holdings 5.0k $19k -5% Dec 2024
 View chart
Wells Fargo & Company 4.8k $7.9k 2% Dec 2024
 View chart
Ronald Blue Trust 4.5k $7.3k 0% Dec 2024
 View chart
Creative Financial Designs 3.0k $4.9k 46% Dec 2024
 View chart
WR Wealth Planners 2.0k $3.3k 0% Dec 2024
 View chart
Royal Bank of Canada 1.5k $2.0k -43% Dec 2024
 View chart
Bnp Paribas Arbitrage, Snc 1.2k $2.0k -3% Dec 2024
 View chart
Bessemer 1.1k $2.0k 100% Dec 2024
 View chart
Truvestments Capital 1.1k $1.8k 0% Dec 2024
 View chart
FMR 847.00 $1.4k -62% Dec 2024
 View chart
Jpmorgan Chase & Co 619.00 $1.0k 0% Dec 2024
 View chart
EverSource Wealth Advisors 431.00 $703.004100 155% Dec 2024
 View chart
SBI Securities 106.00 $173.002600 100% Dec 2024
 View chart
Citigroup 20.00 $33.000000 -9% Dec 2024
 View chart
National Bank Of Canada /fi/ 1.00 $2.000000 0% Dec 2024
 View chart

Who sold out of Pds Biotechnology Ord?

Fund or Company Name
Date Sold
Shares Held
Valued At
Amussen Hunsaker & Associates Sep 2024 75k $287k
Point72 Asia Sep 2024 22k $86k
Cubist Systematic Strategies Sep 2024 18k $70k
Qube Research & Technologies Sep 2024 16k $60k
Invesco Sep 2024 14k $53k
Charles Schwab Investment Management Sep 2024 13k $51k
Lazari Capital Management Sep 2024 13k $50k
LPL Financial Sep 2024 10k $40k
Point72 Sep 2024 50.00 $191.000000
NISA Investment Advisors Sep 2024 18.00 $68.999400